CLEARPOINT NEURO INC (CLPT) Stock Price, Quote, News and Overview
NASDAQ:CLPT - Nasdaq - US18507C1036 - Common Stock - Currency: USD
CLPT Quote, Performance and Key Statistics
16.38
-0.34 (-2.03%)
The current stock price of CLPT is 16.38 USD. In the past month the price decreased by -5.96%. In the past year, price increased by 129.99%.
CLPT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.9 | 234.07B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.63 | 210.79B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.59 | 153.85B | ||
| SYK | STRYKER CORP | 31.82 | 147.88B | ||
| MDT | MEDTRONIC PLC | 16.89 | 115.62B | ||
| BDX | BECTON DICKINSON AND CO | 16.56 | 66.13B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.77 | 42.91B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.17 | 41.38B | ||
| IDXX | IDEXX LABORATORIES INC | 41.21 | 37.96B | ||
| DXCM | DEXCOM INC | 55 | 35.45B | ||
| RMD | RESMED INC | 25.98 | 33.73B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.79 | 24.42B |
Related stock screener links
About CLPT
Company Profile
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 107 full-time employees. The company went IPO on 2019-07-03. The firm provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. The company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. The company also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
Company Info
CLEARPOINT NEURO INC
120 S. Sierra Avenue, Suite 100
Solana Beach CALIFORNIA 92618 US
CEO: Joseph M. Burnett
Employees: 107
Company Website: https://www.clearpointneuro.com/
Investor Relations: https://ir.stockpr.com/clearpointneuro/overview
Phone: 19499006833
CLEARPOINT NEURO INC / CLPT FAQ
What is the stock price of CLEARPOINT NEURO INC today?
The current stock price of CLPT is 16.38 USD. The price decreased by -2.03% in the last trading session.
What is the ticker symbol for CLEARPOINT NEURO INC stock?
The exchange symbol of CLEARPOINT NEURO INC is CLPT and it is listed on the Nasdaq exchange.
On which exchange is CLPT stock listed?
CLPT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CLEARPOINT NEURO INC stock?
9 analysts have analysed CLPT and the average price target is 22.78 USD. This implies a price increase of 39.07% is expected in the next year compared to the current price of 16.38. Check the CLEARPOINT NEURO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CLEARPOINT NEURO INC worth?
CLEARPOINT NEURO INC (CLPT) has a market capitalization of 451.76M USD. This makes CLPT a Small Cap stock.
How many employees does CLEARPOINT NEURO INC have?
CLEARPOINT NEURO INC (CLPT) currently has 107 employees.
What are the support and resistance levels for CLEARPOINT NEURO INC (CLPT) stock?
CLEARPOINT NEURO INC (CLPT) has a support level at 16.71 and a resistance level at 18.9. Check the full technical report for a detailed analysis of CLPT support and resistance levels.
Is CLEARPOINT NEURO INC (CLPT) expected to grow?
The Revenue of CLEARPOINT NEURO INC (CLPT) is expected to grow by 34.32% in the next year. Check the estimates tab for more information on the CLPT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CLEARPOINT NEURO INC (CLPT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CLPT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CLPT, evaluating the profitability, health, valuation and growth aspects
- CLEARPOINT NEURO INC (CLPT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CLEARPOINT NEURO INC (CLPT) Sales and EPS estimates to see what analysts future expectations are.
- CLEARPOINT NEURO INC (CLPT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CLEARPOINT NEURO INC (CLPT) Insider and Institutional Ownership to learn about the owners and their transactions.
- CLEARPOINT NEURO INC (CLPT) Stock Chart to make your own analysis
- CLEARPOINT NEURO INC (CLPT) Latest news and press-releases to stay up to date.
Does CLEARPOINT NEURO INC (CLPT) stock pay dividends?
CLPT does not pay a dividend.
When does CLEARPOINT NEURO INC (CLPT) report earnings?
CLEARPOINT NEURO INC (CLPT) will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of CLEARPOINT NEURO INC (CLPT)?
CLEARPOINT NEURO INC (CLPT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).
What is the Short Interest ratio of CLEARPOINT NEURO INC (CLPT) stock?
The outstanding short interest for CLEARPOINT NEURO INC (CLPT) is 2.57% of its float. Check the ownership tab for more information on the CLPT short interest.
CLPT Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CLPT. When comparing the yearly performance of all stocks, CLPT is one of the better performing stocks in the market, outperforming 96.93% of all stocks.
CLPT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CLPT. While CLPT has a great health rating, there are worries on its profitability.
CLPT Financial Highlights
Over the last trailing twelve months CLPT reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS increased by 23.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.15% | ||
| ROE | -62.57% | ||
| Debt/Equity | 0 |
CLPT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to CLPT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 24.53% and a revenue growth 34.32% for CLPT